Brian Wynhoven

3.2k total citations
30 papers, 2.1k citations indexed

About

Brian Wynhoven is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Brian Wynhoven has authored 30 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Virology, 26 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Brian Wynhoven's work include HIV Research and Treatment (27 papers), HIV/AIDS drug development and treatment (26 papers) and HIV/AIDS Research and Interventions (18 papers). Brian Wynhoven is often cited by papers focused on HIV Research and Treatment (27 papers), HIV/AIDS drug development and treatment (26 papers) and HIV/AIDS Research and Interventions (18 papers). Brian Wynhoven collaborates with scholars based in Canada, United States and United Kingdom. Brian Wynhoven's co-authors include P. Richard Harrigan, Julio Montaner, Zabrina L. Brumme, Robert S. Hogg, Chanson J. Brumme, Winnie Dong, Benita Yip, Michael V. O’Shaughnessy, Theresa Mo and Christopher S. Alexander and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Brian Wynhoven

30 papers receiving 2.0k citations

Peers

Brian Wynhoven
Stephen Raffanti United States
Barry Peters United Kingdom
Maria Prins Netherlands
John P. Phair United States
Brian Wynhoven
Citations per year, relative to Brian Wynhoven Brian Wynhoven (= 1×) peers David Dalmau

Countries citing papers authored by Brian Wynhoven

Since Specialization
Citations

This map shows the geographic impact of Brian Wynhoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Wynhoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Wynhoven more than expected).

Fields of papers citing papers by Brian Wynhoven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Wynhoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Wynhoven. The network helps show where Brian Wynhoven may publish in the future.

Co-authorship network of co-authors of Brian Wynhoven

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Wynhoven. A scholar is included among the top collaborators of Brian Wynhoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Wynhoven. Brian Wynhoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brumme, Chanson J., Luke C. Swenson, Brian Wynhoven, et al.. (2012). Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay. PLoS ONE. 7(8). e43882–e43882. 9 indexed citations
2.
Woods, Conan K., Chanson J. Brumme, Tommy F. Liu, et al.. (2012). Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool. Journal of Clinical Microbiology. 50(6). 1936–1942. 140 indexed citations
3.
Linning, Rob, John P. Fellers, Matthew Dickinson, et al.. (2011). Gene discovery in EST sequences from the wheat leaf rust fungus Puccinia triticina sexual spores, asexual spores and haustoria, compared to other rust and corn smut fungi. BMC Genomics. 12(1). 161–161. 38 indexed citations
4.
Swenson, Luke C., Brian Wynhoven, Theresa Mo, et al.. (2011). “Dynamic Range” of Inferred Phenotypic HIV Drug Resistance Values in Clinical Practice. PLoS ONE. 6(2). e17402–e17402. 3 indexed citations
5.
Swenson, Luke C., Andrew Low, Alexander Thielen, et al.. (2010). Improved Detection of CXCR4-Using HIV by V3 Genotyping: Application of Population-Based and “Deep” Sequencing to Plasma RNA and Proviral DNA. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(5). 506–510. 66 indexed citations
6.
Harrigan, P. Richard, Brian Wynhoven, Viviane D. Lima, et al.. (2008). Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency. AIDS. 22(18). 2501–2508. 13 indexed citations
7.
Ehteshami, Maryam, Greg L. Beilhartz, Egor P. Tchesnokov, et al.. (2008). Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent Mechanisms. Journal of Biological Chemistry. 283(32). 22222–22232. 69 indexed citations
8.
Fahey, Jonathan M., Mark Zanin, David Tyssen, et al.. (2007). N348I in the Connection Domain of HIV-1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance. PLoS Medicine. 4(12). e335–e335. 138 indexed citations
9.
Brumme, Zabrina L., Chanson J. Brumme, Celia Chui, et al.. (2007). Effects of Human Leukocyte Antigen Class I Genetic Parameters on Clinical Outcomes and Survival after Initiation of Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 195(11). 1694–1704. 25 indexed citations
10.
Loutfy, Mona, J. Raboud, Joan Montaner, et al.. (2006). Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide☆. Antiviral Research. 75(1). 58–63. 15 indexed citations
11.
Deforche, Koen, Ricardo Camacho, Zehava Grossman, et al.. (2006). Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. Infection Genetics and Evolution. 7(3). 382–390. 26 indexed citations
12.
Wood, Evan, Robert S. Hogg, Benita Yip, et al.. (2005). Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. AIDS. 19(11). 1189–1195. 41 indexed citations
13.
Harrigan, P. Richard, Theresa Mo, Brian Wynhoven, et al.. (2005). Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors. AIDS. 19(6). 549–554. 34 indexed citations
14.
Harrigan, P. Richard, Brian Wynhoven, Zabrina L. Brumme, et al.. (2005). HIV‐1 Drug Resistance: Degree of Underestimation by a Cross‐Sectional versus a Longitudinal Testing Approach. The Journal of Infectious Diseases. 191(8). 1325–1330. 32 indexed citations
15.
Brumme, Zabrina L., James Goodrich, Howard Mayer, et al.. (2005). Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals. The Journal of Infectious Diseases. 192(3). 466–474. 221 indexed citations
16.
Harrigan, P. Richard, Robert S. Hogg, Winnie Dong, et al.. (2005). Predictors of HIV Drug‐Resistance Mutations in a Large Antiretroviral‐Naive Cohort Initiating Triple Antiretroviral Therapy. The Journal of Infectious Diseases. 191(3). 339–347. 348 indexed citations
17.
Brumme, Zabrina L., Winnie Dong, Benita Yip, et al.. (2004). Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy. AIDS. 18(4). F1–F9. 67 indexed citations
18.
Brumme, Zabrina L., Keith Chan, Brian Wynhoven, et al.. (2004). Antiretroviral Resistance among HIV‐Infected Persons Who Have Died in British Columbia, in the Era of Modern Antiretroviral Therapy. The Journal of Infectious Diseases. 190(2). 285–292. 32 indexed citations
19.
Brumme, Zabrina L., Keith Chan, Winnie Dong, et al.. (2002). No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS. 16(14). 1929–1933. 31 indexed citations
20.
Côté, Hélène C. F., Zabrina L. Brumme, Kevin J.P. Craib, et al.. (2002). Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients. New England Journal of Medicine. 346(11). 811–820. 467 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026